LexDanaLexDanabeta
Inventor

Thomas J. Greshock

Inventor
Collegeville, PA, US

Overview

27→
Patents
2013–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 27 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes25%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
C07CAcyclic or carbocyclic compounds5%
C07BGeneral methods of organic chemistry3%
PatentTitleYear
11,066,3963-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors202111,026,958Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors202110,968,210Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels202110,870,630Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors202010,519,147Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels201910,442,778N1-phenylpropane-1,2-diamine compounds with selective activity in voltage-gated sodium channels201910,221,167Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels201910,022,461Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrilary tangles20189,994,587HIV protease inhibitors20189,840,481'Allosteric modulators of nicotinic acetylcholine receptors'20179,834,526HIV protease inhibitors20179,809,568'Compounds inhibiting leucine-rich repeat kinase enzyme activity'20179,808,542'Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrillary'20179,737,545'HIV protease inhibitors'20179,718,818'Compounds inhibiting leucine-rich repeat kinase enzyme activity'20179,708,273'Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators'20179,440,952'Compounds inhibiting leucine-rich repeat kinase enzyme activity'20169,315,475'HIV protease inhibitors'20169,284,312'N-methyl tetrahydroquinoline M1 receptor positive allosteric modulators'20169,260,418'Pyranyl aryl methyl benzoquinolinone M1 receptor positive allosteric modulators'20169,233,977'Leucine-rich repeat kinase enzyme activity'20168,883,810'Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators'20148,846,702'Pyranyl aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators'20148,664,387'Pyridoquinazolinone M1 receptor positive allosteric modulators'20148,664,234'Dihydrobenzoquinazolinone M1 receptor positive allosteric modulators'20148,557,832'Aryl methyl benzoquinazolinine M1 receptor positive allosteric modulators'20138,383,638'Aminobenzoquinazolinone M1 receptor positive allosteric modulators'2013

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2013–2021Patents assigned to MERCK SHARP & DOHME (27)· patent assignee history
2013–2021Patents assigned to GRESHOCK THOMAS J (11)· patent assignee history
2013–2016Patents assigned to KUDUK SCOTT D (6)· patent assignee history
2013–2021Based in Collegeville, PA, US· patent location history
2014–2017Patents assigned to CHANG RONALD K (5)· patent assignee history
2014Based in West Point, PA, US· patent location history
2016–2018Patents assigned to MERCK CANADA INC (4)· patent assignee history
2016Based in Harleysville, PA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK SHARP & DOHME272013–2021
GRESHOCK THOMAS Jself112013–2021
KUDUK SCOTT D62013–2016
CHANG RONALD K52014–2017
MERCK CANADA INC42016–2018
Locations
LocationPatentsSpan
Collegeville, Pennsylvania, US242013–2021
Harleysville, Pennsylvania, US22016
West Point, Pennsylvania, US12014